Publications by authors named "H Haji"

Breast cancer remains a significant contributor to cancer-related deaths among women globally. We seek for this study to examine the correlation between the incidence rates of breast cancer and newly identified risk factors. Additionally, we aim to utilize machine learning models to predict breast cancer incidence at a country level.

View Article and Find Full Text PDF

Background: Previous studies have shown mortality benefits with corticosteroids in Coronavirus disease-19 (COVID-19). However, there is inconsistency regarding the use of methylprednisolone over dexamethasone in COVID-19, and this has not been extensively evaluated in patients with a history of asthma. This study aims to investigate and compare the effectiveness and safety of methylprednisolone and dexamethasone in critically ill patients with asthma and COVID-19.

View Article and Find Full Text PDF

Purpose: Selection of appropriate adjuvant therapy to ultimately reduce the risk of breast cancer (BC) recurrence is a challenge for medical oncologists. Several automated risk prediction models have been developed using retrospective clinical data and have evolved significantly over the years in terms of predictors of recurrence, data usage, and predictive techniques (statistical/machine learning [ML]).

Methods: Following PRISMA guidelines, we performed a systematic literature review of the aforementioned statistical and ML models published between January 2008 and December 2022 through searching five digital databases-PubMed, ScienceDirect, Scopus, Cochrane, and Web of Science.

View Article and Find Full Text PDF
Article Synopsis
  • This study aimed to determine if helmet noninvasive ventilation lowers mortality rates and improves health-related quality of life (HRQoL) for COVID-19 pneumonia patients with acute hypoxemic respiratory failure.
  • The research involved a multicenter trial with 320 adult participants, who were randomly assigned to receive either helmet ventilation or standard respiratory support, assessing their outcomes over 180 days.
  • The results showed no significant difference in 180-day mortality (39.6% vs. 41.1%) or HRQoL measures between the helmet ventilation and standard support groups, indicating helmet ventilation was not more effective.
View Article and Find Full Text PDF